© 1997 by Oxford University Press
Epidermal growth factor receptor family and chemosensitization
J Mendelsohn and Z Fan
| You have reached the most complete version of this article accessible without further authentication.
More complete versions are available. Link to article |
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. A. Forastiere and B. A. Burtness Epidermal Growth Factor Receptor Inhibition in Head and Neck Cancer--More Insights, but More Questions J. Clin. Oncol., June 1, 2007; 25(16): 2152 - 2155. [Full Text] [PDF]
|
|
|
|
|
|
D. G. Pfister, Y. B. Su, D. H. Kraus, S. L. Wolden, E. Lis, T. B. Aliff, A. J. Zahalsky, S. Lake, M. N. Needle, A. R. Shaha, et al. Concurrent Cetuximab, Cisplatin, and Concomitant Boost Radiotherapy for Locoregionally Advanced, Squamous Cell Head and Neck Cancer: A Pilot Phase II Study of a New Combined-Modality Paradigm J. Clin. Oncol., March 1, 2006; 24(7): 1072 - 1078. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Savellano, B. W. Pogue, P. J. Hoopes, E. S. Vitetta, and K. D. Paulsen Multiepitope HER2 Targeting Enhances Photoimmunotherapy of HER2-Overexpressing Cancer Cells with Pyropheophorbide-a Immunoconjugates Cancer Res., July 15, 2005; 65(14): 6371 - 6379. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Nakamura, M. Oka, H. Soda, K. Shiozawa, M. Yoshikawa, A. Itoh, Y. Ikegami, J. Tsurutani, K. Nakatomi, T. Kitazaki, et al. Gefitinib ("Iressa", ZD1839), an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Reverses Breast Cancer Resistance Protein/ABCG2-Mediated Drug Resistance Cancer Res., February 15, 2005; 65(4): 1541 - 1546. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Savellano and T. Hasan Photochemical Targeting of Epidermal Growth Factor Receptor: A Mechanistic Study Clin. Cancer Res., February 15, 2005; 11(4): 1658 - 1668. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. F. McCarty Targeting Multiple Signaling Pathways as a Strategy for Managing Prostate Cancer: Multifocal Signal Modulation Therapy Integr Cancer Ther, December 1, 2004; 3(4): 349 - 380. [Abstract] [PDF]
|
|
|
|
 |
|
 J. Feng, J. Park, P. Cron, D. Hess, and B. A. Hemmings Identification of a PKB/Akt Hydrophobic Motif Ser-473 Kinase as DNA-dependent Protein Kinase J. Biol. Chem., September 24, 2004; 279(39): 41189 - 41196. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Vanhoefer, M. Tewes, F. Rojo, O. Dirsch, N. Schleucher, O. Rosen, J. Tillner, A. Kovar, A. H. Braun, T. Trarbach, et al. Phase I Study of the Humanized Antiepidermal Growth Factor Receptor Monoclonal Antibody EMD72000 in Patients With Advanced Solid Tumors That Express the Epidermal Growth Factor Receptor J. Clin. Oncol., January 1, 2004; 22(1): 175 - 184. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Herbst and P. A. Bunn Jr. Targeting the Epidermal Growth Factor Receptor in Non-Small Cell Lung Cancer Clin. Cancer Res., December 1, 2003; 9(16): 5813 - 5824. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Niwa, A. L. Wentzel, M. Li, W. E. Gooding, V. W. Y. Lui, and J. R. Grandis Antitumor Effects of Epidermal Growth Factor Receptor Antisense Oligonucleotides in Combination with Docetaxel in Squamous Cell Carcinoma of the Head and Neck Clin. Cancer Res., October 15, 2003; 9(13): 5028 - 5035. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. J. Abrams, L. J. Murray, E. Pesenti, V. Walker Holway, T. Colombo, L. B. Lee, J. M. Cherrington, and N. K. Pryer Preclinical evaluation of the tyrosine kinase inhibitor SU11248 as a single agent and in combination with "standard of care" therapeutic agents for the treatment of breast cancer Mol. Cancer Ther., October 1, 2003; 2(10): 1011 - 1021. [Abstract] [Full Text]
|
|
|
|
|
|
J. W. Lim, H. Kim, and K. H. Kim Expression of Ku70 and Ku80 Mediated by NF-kappa B and Cyclooxygenase-2 Is Related to Proliferation of Human Gastric Cancer Cells J. Biol. Chem., November 22, 2002; 277(48): 46093 - 46100. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Tsutsui, A. Kataoka, S. Ohno, S. Murakami, J. Kinoshita, and Y. Hachitanda Prognostic and Predictive Value of Epidermal Growth Factor Receptor in Recurrent Breast Cancer Clin. Cancer Res., November 1, 2002; 8(11): 3454 - 3460. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Bianco, G. Tortora, R. Bianco, R. Caputo, B. M. Veneziani, R. Caputo, V. Damiano, T. Troiani, G. Fontanini, D. Raben, et al. Enhancement of Antitumor Activity of Ionizing Radiation by Combined Treatment with the Selective Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor ZD1839 (Iressa) Clin. Cancer Res., October 1, 2002; 8(10): 3250 - 3258. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Hida, K.-i. Kozaki, H. Ito, O. Miyaishi, Y. Tatematsu, T. Suzuki, K. Matsuo, T. Sugiura, M. Ogawa, T. Takahashi, et al. Significant Growth Inhibition of Human Lung Cancer Cells Both in Vitro and in Vivo by the Combined Use of a Selective Cyclooxygenase 2 Inhibitor, JTE-522, and Conventional Anticancer Agents Clin. Cancer Res., July 1, 2002; 8(7): 2443 - 2447. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-M. Huang, J. Li, and P. M. Harari Molecular Inhibition of Angiogenesis and Metastatic Potential in Human Squamous Cell Carcinomas after Epidermal Growth Factor Receptor Blockade Mol. Cancer Ther., May 1, 2002; 1(7): 507 - 514. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Forastiere, W. Koch, A. Trotti, and D. Sidransky Head and Neck Cancer N. Engl. J. Med., December 27, 2001; 345(26): 1890 - 1900. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Benhar, I. Dalyot, D. Engelberg, and A. Levitzki Enhanced ROS Production in Oncogenically Transformed Cells Potentiates c-Jun N-Terminal Kinase and p38 Mitogen-Activated Protein Kinase Activation and Sensitization to Genotoxic Stress Mol. Cell. Biol., October 15, 2001; 21(20): 6913 - 6926. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Ciardiello and G. Tortora A Novel Approach in the Treatment of Cancer: Targeting the Epidermal Growth Factor Receptor Clin. Cancer Res., October 1, 2001; 7(10): 2958 - 2970. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Robert, M. P. Ezekiel, S. A. Spencer, R. F. Meredith, J. A. Bonner, M. B. Khazaeli, M. N. Saleh, D. Carey, A. F. LoBuglio, R. H. Wheeler, et al. Phase I Study of Anti-Epidermal Growth Factor Receptor Antibody Cetuximab in Combination With Radiation Therapy in Patients With Advanced Head and Neck Cancer J. Clin. Oncol., July 1, 2001; 19(13): 3234 - 3243. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. I. Sartor, H. Zhou, E. Kozlowska, K. Guttridge, E. Kawata, L. Caskey, J. Harrelson, N. Hynes, S. Ethier, B. Calvo, et al. HER4 Mediates Ligand-Dependent Antiproliferative and Differentiation Responses in Human Breast Cancer Cells Mol. Cell. Biol., July 1, 2001; 21(13): 4265 - 4275. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Shin, N. J. Donato, R. Perez-Soler, H. J. C. Shin, J. Y. Wu, P. Zhang, K. Lawhorn, F. R. Khuri, B. S. Glisson, J. Myers, et al. Epidermal Growth Factor Receptor-targeted Therapy with C225 and Cisplatin in Patients with Head and Neck Cancer Clin. Cancer Res., May 1, 2001; 7(5): 1204 - 1213. [Abstract] [Full Text]
|
|
|
|
|
|
C. Bianco, R. Bianco, G. Tortora, V. Damiano, P. Guerrieri, P. Montemaggi, J. Mendelsohn, S. De Placido, A. R. Bianco, and F. Ciardiello Antitumor Activity of Combined Treatment of Human Cancer Cells with Ionizing Radiation and Anti-Epidermal Growth Factor Receptor Monoclonal Antibody C225 plus Type I Protein Kinase A Antisense Oligonucleotide Clin. Cancer Res., November 1, 2000; 6(11): 4343 - 4350. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. D. Woodworth, D. Gaiotti, E. Michael, L. Hansen, and M. Nees Targeted Disruption of the Epidermal Growth Factor Receptor Inhibits Development of Papillomas and Carcinomas from Human Papillomavirus-immortalized Keratinocytes Cancer Res., August 1, 2000; 60(16): 4397 - 4402. [Abstract] [Full Text]
|
|
|
|
|
|
F. Ciardiello, R. Caputo, R. Bianco, V. Damiano, G. Pomatico, S. De Placido, A. R. Bianco, and G. Tortora Antitumor Effect and Potentiation of Cytotoxic Drugs Activity in Human Cancer Cells by ZD-1839 (Iressa), an Epidermal Growth Factor Receptor-selective Tyrosine Kinase Inhibitor Clin. Cancer Res., May 1, 2000; 6(5): 2053 - 2063. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Mendelsohn Blockade of Receptors for Growth Factors: An Anticancer Therapy -- The Fourth Annual Joseph H. Burchenal American Association for Cancer Research Clinical Research Award Lecture Clin. Cancer Res., March 1, 2000; 6(3): 747 - 753. [Full Text]
|
|
|
|
|
|
L. Milas, K. Mason, N. Hunter, S. Petersen, M. Yamakawa, K. Ang, J. Mendelsohn, and Z. Fan In Vivo Enhancement of Tumor Radioresponse by C225 Antiepidermal Growth Factor Receptor Antibody Clin. Cancer Res., February 1, 2000; 6(2): 701 - 708. [Abstract] [Full Text]
|
|
|
|
|
|
N. J. Donato, M. Perez, H. Kang, Z. H. Siddik, Y.-H. Ling, and R. Perez-Soler EGF Receptor and p21WAF1 Expression are Reciprocally Altered as ME-180 Cervical Carcinoma Cells Progress from High to Low Cisplatin Sensitivity Clin. Cancer Res., January 1, 2000; 6(1): 193 - 202. [Abstract] [Full Text]
|
|
|
|
|
|
T. Akimoto, N. R. Hunter, L. Buchmiller, K. Mason, K. K. Ang, and L. Milas Inverse Relationship between Epidermal Growth Factor Receptor Expression and Radiocurability of Murine Carcinomas Clin. Cancer Res., October 1, 1999; 5(10): 2884 - 2890. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Dent, D. B. Reardon, J. S. Park, G. Bowers, C. Logsdon, K. Valerie, and R. Schmidt-Ullrich Radiation-induced Release of Transforming Growth Factor alpha Activates the Epidermal Growth Factor Receptor and Mitogen-activated Protein Kinase Pathway in Carcinoma Cells, Leading to Increased Proliferation and Protection from Radiation-induced Cell Death Mol. Biol. Cell, August 1, 1999; 10(8): 2493 - 2506. [Abstract] [Full Text]
|
|
|
|
|
|
S.-M. Huang, J. M. Bock, and P. M. Harari Epidermal Growth Factor Receptor Blockade with C225 Modulates Proliferation, Apoptosis, and Radiosensitivity in Squamous Cell Carcinomas of the Head and Neck Cancer Res., April 1, 1999; 59(8): 1935 - 1940. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Tortora, R. Caputo, G. Pomatico, S. Pepe, A. R. Bianco, S. Agrawal, J. Mendelsohn, and F. Ciardiello Cooperative Inhibitory Effect of Novel Mixed Backbone Oligonucleotide Targeting Protein Kinase A in Combination with Docetaxel and Anti-Epidermal Growth Factor-Receptor Antibody on Human Breast Cancer Cell Growth Clin. Cancer Res., April 1, 1999; 5(4): 875 - 881. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Ciardiello, R. Bianco, V. Damiano, S. De Lorenzo, S. Pepe, S. De Placido, Z. Fan, J. Mendelsohn, A. R. Bianco, and G. Tortora Antitumor Activity of Sequential Treatment with Topotecan and Anti-Epidermal Growth Factor Receptor Monoclonal Antibody C225 Clin. Cancer Res., April 1, 1999; 5(4): 909 - 916. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Bandyopadhyay, M. Mandal, L. Adam, J. Mendelsohn, and R. Kumar Physical Interaction between Epidermal Growth Factor Receptor and DNA-dependent Protein Kinase in Mammalian Cells J. Biol. Chem., January 16, 1998; 273(3): 1568 - 1573. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||